GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris.
Industry preview: Eye care companies announce presentations ahead of ASRS meeting
Companies in the retina space announced presentations ahead of the American Society of Retina Specialists meeting, to be held 17-20 July
Alopecia areata and underlying corneal pathologies
Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata
Impact report highlights outcomes of Moorfields Eye Charity programmes
The organisation has secured £72.75 million for its new eye health centre
VEGF-C and VEGF-D signaling pathways: Potential targets for treating wet AMD
A novel formulation may prevent blood vessel growth and vascular leakage in the retina
Semaglutide may be associated with non-arteritic ischemic optic neuropathy (NAION)
GLP-1 receptor agonists, such as Wegovy, Ozempic and Novo Nordisk, are becoming more prolific
Beacon Therapeutics announces new board members, funding to support XLRP and AMD programmes
The company has secured $170 million (approximately €157 million) in Series B funding